Table 3.
Predictors of in-hospital mortality and overall postdischarge mortality in Medicare beneficiaries hospitalised for CLD in 2005–2010*
| Predictors | In-hospital mortality | Postdischarge mortality† |
|---|---|---|
| OR (95% CI) | OR (95% CI) | |
| Age | ||
| 65–69 | Ref | Ref |
| <65 | 0.83 (0.69 to 0.99) | 0.83 (0.72 to 0.94) |
| 70–74 | 1.06 (0.85 to 1.31) | 1.16 (0.99 to 1.35) |
| 75–79 | 1.28 (1.03 to 1.60) | 1.33 (1.13 to 1.56) |
| 80–84 | 0.91 (0.71 to 1.18) | 1.23 (1.04 to 1.46) |
| 85 and over | 0.92 (0.70 to 1.21) | 1.51 (1.27 to 1.80) |
| Gender | ||
| Female | Ref | Ref |
| Male | 1.27 (1.11 to 1.44) | 1.34 (1.22 to 1.46) |
| Race | ||
| White | Ref | Ref |
| Black | 1.18 (0.96 to 1.44) | 0.81 (0.70 to 0.95) |
| Hispanic | 0.74 (0.52 to 1.04) | 0.91 (0.73 to 1.13) |
| Other | 1.11 (0.82 to 1.51) | 0.79 (0.63 to 0.99) |
| ESRD | ||
| No | Ref | Ref |
| Yes | 0.73 (0.55 to 0.98) | 1.14 (0.93 to 1.40) |
| Number of admissions | ||
| 1 | Ref | Ref |
| ≥2 | 1.50 (1.31 to 1.73) | 1.62 (1.46 to 1.80) |
| Discharge destination | ||
| Home | NA | Ref |
| Continued care | NA | 2.51 (2.29 to 2.76) |
| Hospice | NA | 44.98 (33.0161.28) |
| Region | ||
| Northeast | Ref | Ref |
| South | 0.95 (0.81 to 1.13) | 1.27 (1.12 to 1.43) |
| Midwest | 0.79 (0.65 to 0.96) | 1.10 (0.96 to 1.26) |
| West | 0.84 (0.65 to 1.10) | 1.33 (1.11 to 1.60) |
| California | 0.95 (0.74 to 1.22) | 1.23 (1.02 to 1.47) |
| Calendar year | 0.90 (0.87 to 0.94) | 1.00 (0.98 to 1.03) |
| Number of diagnosis | 1.24 (1.17 to 1.32) | 1.06 (1.03 to 1.09) |
| Number of procedures | 1.36 (1.31 to 1.41) | 0.98 (0.96 to 1.01) |
| Charlson score | 1.01 (0.98 to 1.05) | 1.24 (1.21 to 1.28) |
| LOS | 1.01 (1.00 to 1.02) | 1.02 (1.01 to 1.03) |
*Data in 2008 were excluded from analysis due to missing information on patient's residence region.
†Patients were followed up to March of the year following the hospitalisation.
CLD, chronic liver disease; ESRD, end-stage renal disease; LOS, length of stay; NA, not applicable.